6/24/24 16:29 | 6/20/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 79 | 0.2584 | 0 | 305 | 81 | 680 | D | | | | | | | | | | | | | | |
6/20/24 16:15 | 6/18/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 4 | 0.2477 | 0 | 18 | 33 | 71 | D | | | | | | | | | | | | | | |
9/25/23 16:21 | 9/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 90 | 1.38 | 0 | 65 | 21 | 375 | D | | | | | | | | | | | | | | |
5/11/23 17:08 | 5/10/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 47 | 1.56 | 0 | 30 | 47 | 93 | D | | | | | | | | | | | | | | |
5/9/23 17:00 | 5/8/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Johnson Bruce S | MD | O | SVP,Chie | P | 21 | 1.57 | 0 | 14 | 11 | 139 | D | | | | | | | | | | | | | | |
2/23/23 18:23 | 2/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 712 | 1.78 | 0 | 400 | 5 | 8,489 | D | | | | | | | | | | | | | | |
2/17/23 17:29 | 2/15/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 3,028 | 2.00 | 0 | 1,515 | 23 | 8,089 | D | | | | | | | | | | | | | | |
2/13/23 17:45 | 2/9/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P | 37 | 3.24 | 0 | 11 | 0 | 6,574 | D | | | | | | | | | | | | | | |
12/27/22 18:41 | 12/22/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P | 248 | 2.25 | 0 | 110 | 55 | 310 | D | | | | | | | | | | | | | | |
11/18/22 16:01 | 11/17/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 37 | 1.87 | 0 | 20 | 46 | 63 | D | | | | | | | | | | | | | | |
11/16/22 16:26 | 11/14/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 309 | 1.55 | 0 | 200 | New | 200 | D | | | | | | | | | | | | | | |
11/14/22 16:14 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Pearson Timothy R | MD | D | | P | 25 | 1.29 | 0 | 19 | 370 | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Semerjian Harout | MD | DO | CEO | P | 32 | 1.29 | 0 | 25 | New | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 21 | 1.06 | 0 | 20 | 54 | 57 | D | | | | | | | | | | | | | | |
11/14/22 16:11 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | O | SVP of R | P | 53 | 1.17 | 0 | 45 | 14 | 371 | D | | | | | | | | | | | | | | |
11/14/22 16:04 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Girard Armand | MD | O | SVP,Chie | P | 7 | 1.05 | 0 | 7 | 29 | 29 | D | | | | | | | | | | | | | | |